Gyre Therapeutics, Inc. GYRE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s short-term investments?
- Gyre Therapeutics, Inc. (GYRE) reported short-term investments of $12.31M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s short-term investments changed year-over-year?
- Gyre Therapeutics, Inc.'s short-term investments decreased by 17.1% year-over-year, from $14.85M to $12.31M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s short-term investments?
- Over 3 years (2020 to 2025), Gyre Therapeutics, Inc.'s short-term investments has grown at a -32.1% compound annual growth rate (CAGR), from $48.99M to $15.36M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.